company background image
1011 logo

China NT Pharma Group SEHK:1011 Stock Report

Last Price

HK$0.028

Market Cap

HK$73.9m

7D

21.7%

1Y

-44.0%

Updated

21 Jun, 2024

Data

Company Financials

China NT Pharma Group Company Limited

SEHK:1011 Stock Report

Market Cap: HK$73.9m

1011 Stock Overview

Engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People’s Republic of China.

1011 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

China NT Pharma Group Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China NT Pharma Group
Historical stock prices
Current Share PriceHK$0.028
52 Week HighHK$0.10
52 Week LowHK$0.017
Beta-1.12
11 Month Change16.67%
3 Month Change-15.15%
1 Year Change-44.00%
33 Year Change-76.47%
5 Year Change-96.27%
Change since IPO-99.27%

Recent News & Updates

Recent updates

A Look At The Intrinsic Value Of China NT Pharma Group Company Limited (HKG:1011)

Mar 06
A Look At The Intrinsic Value Of China NT Pharma Group Company Limited (HKG:1011)

China NT Pharma Group Company Limited's (HKG:1011) Price Is Right But Growth Is Lacking

Dec 29
China NT Pharma Group Company Limited's (HKG:1011) Price Is Right But Growth Is Lacking

Estimating The Intrinsic Value Of China NT Pharma Group Company Limited (HKG:1011)

Oct 30
Estimating The Intrinsic Value Of China NT Pharma Group Company Limited (HKG:1011)

Is China NT Pharma Group (HKG:1011) Using Too Much Debt?

Apr 13
Is China NT Pharma Group (HKG:1011) Using Too Much Debt?

Shareholder Returns

1011HK PharmaceuticalsHK Market
7D21.7%-4.1%0.6%
1Y-44.0%-3.5%2.4%

Return vs Industry: 1011 underperformed the Hong Kong Pharmaceuticals industry which returned -6.2% over the past year.

Return vs Market: 1011 underperformed the Hong Kong Market which returned 2.1% over the past year.

Price Volatility

Is 1011's price volatile compared to industry and market?
1011 volatility
1011 Average Weekly Movement18.4%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1011's share price has been volatile over the past 3 months.

Volatility Over Time: 1011's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
199516David Ngwww.ntpharma.com

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People’s Republic of China. It manufactures, sells, and trades in prescription medicines; offers products in the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products. The company also provides marketing and promotion services to suppliers, and logistics and consulting services.

China NT Pharma Group Company Limited Fundamentals Summary

How do China NT Pharma Group's earnings and revenue compare to its market cap?
1011 fundamental statistics
Market capHK$73.95m
Earnings (TTM)-HK$35.99m
Revenue (TTM)HK$7.92m

9.3x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1011 income statement (TTM)
RevenueCN¥7.37m
Cost of RevenueCN¥0
Gross ProfitCN¥7.37m
Other ExpensesCN¥40.86m
Earnings-CN¥33.49m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.013
Gross Margin100.00%
Net Profit Margin-454.67%
Debt/Equity Ratio-101.3%

How did 1011 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.